aTyr Pharma, Inc. (ATYR) vs Rockwell Medical, Inc. (RMTI)

A side-by-side comparison of aTyr Pharma, Inc. and Rockwell Medical, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare

Total return — ATYR vs RMTI

growth of $100 · dividends reinvested · last 2y
ATYR -83.2% (-59.1%/yr)RMTI -54.8% (-32.8%/yr)RMTI compounded faster over this window
0100200300400Start $10020252026$17$45
ATYR RMTI

ATYR vs RMTI: by the numbers

  • •RMTI is the larger company ($30M vs $28M market cap).
  • •Both run net losses; RMTI's is the smaller (-7.33% vs -32003.68% net margin).
  • •RMTI grew revenue faster over the past five years (2.59% vs -38.74% CAGR).

Metrics side by side

Valuation

MetricATYRRMTI
P/S ratio146.250.44
P/B ratio0.570.86
FCF yieldN/A5.10%

Profitability

MetricATYRRMTI
Gross margin-717.37%17.71%
Operating margin-40856.32%-6.52%
Net margin-32003.68%-7.33%
ROE-124.64%-14.49%
ROIC-109.29%-9.60%

Growth (annualized)

MetricATYRRMTI
Revenue CAGR (5Y)-38.74%2.59%
Total return CAGR (5Y)N/A-33.38%

Frequently asked

Which has grown faster, ATYR or RMTI?
Over the past five years, RMTI grew revenue faster — ATYR at a -38.74% CAGR versus RMTI at 2.59%.

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.